Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Intangibles (2021 - 2025)

Bioregenx has reported Intangibles over the past 5 years, most recently at $725000.0 for Q3 2025.

  • For Q3 2025, Intangibles fell 93.58% year-over-year to $725000.0; the TTM value through Sep 2025 reached $725000.0, down 93.58%, while the annual FY2023 figure was $49363.0, 31.73% up from the prior year.
  • Intangibles for Q3 2025 was $725000.0 at Bioregenx, roughly flat from $725000.0 in the prior quarter.
  • Over five years, Intangibles peaked at $11.3 million in Q3 2024 and troughed at $33023.0 in Q3 2023.
  • A 5-year average of $3.1 million and a median of $49363.0 in 2023 define the central range for Intangibles.
  • Biggest five-year swings in Intangibles: surged 34099.3% in 2024 and later tumbled 93.58% in 2025.
  • Year by year, Intangibles stood at $43404.0 in 2021, then fell by 13.66% to $37473.0 in 2022, then surged by 31.73% to $49363.0 in 2023, then soared by 22778.75% to $11.3 million in 2024, then tumbled by 93.58% to $725000.0 in 2025.
  • Business Quant data shows Intangibles for BRGX at $725000.0 in Q3 2025, $725000.0 in Q2 2025, and $11.3 million in Q3 2024.